🔍

ALKYLAMINE - Alkyl Amines

📊 NSE: ALKYLAMINE 🏢 Chemicals 📅 Last Updated: 12/13/2025 18:09

📢 Recent Corporate Announcements

Alkyl Amines Chemicals Announces Opening of Trading Window from February 6, 2026

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 04 Feb 2026, 05:51 PM

Alkyl Amines Chemicals Limited has informed the exchanges that its trading window for insiders will reopen on February 6, 2026. This follows the announcement of the company's unaudited financial results for the quarter and nine months ended December 31, 2025. The trading window is restricted for designated persons and their relatives during the earnings period to prevent insider trading. This is a standard regulatory compliance procedure under SEBI norms.

Trading window for designated persons to reopen on February 6, 2026
Follows the disclosure of unaudited financial results for the period ended December 31, 2025
Compliance with the Code of Conduct for regulating, monitoring, and reporting of insider trading
Standard administrative filing with no impact on company fundamentals

💡 No action is required as this is a routine regulatory filing. Investors should instead focus on the company's Q3 FY26 financial performance results.

Alkyl Amines Q3 PAT Dips 3.4% YoY to ₹42.26 Cr; Revenue Down 4.6%

🔴 NEGATIVE ⭐ 7/10

EARNINGS 📅 03 Feb 2026, 01:31 PM

Alkyl Amines Chemicals Limited reported a subdued performance for the quarter ended December 31, 2025. Revenue from operations declined by 4.6% YoY to ₹354.00 Cr, while Net Profit (PAT) saw a 3.4% YoY decrease to ₹42.26 Cr. On a sequential basis, revenue dropped significantly by 9.1% from ₹389.41 Cr in Q2 FY26. The company's nine-month performance also shows a downward trend, with PAT at ₹134.64 Cr compared to ₹140.10 Cr in the previous year.

Revenue from operations fell 4.6% YoY to ₹354.00 Cr from ₹371.20 Cr.
Net Profit (PAT) decreased to ₹42.26 Cr in Q3 FY26 from ₹43.76 Cr in Q3 FY25.
Quarterly Earnings Per Share (EPS) stood at ₹8.26, down from ₹8.56 YoY.
Total expenses for the quarter were ₹304.77 Cr, compared to ₹318.75 Cr in the year-ago period.
Nine-month revenue for FY26 reached ₹1,148.94 Cr, down from ₹1,185.77 Cr in FY25.

💡 The stock may witness short-term weakness due to declining revenue and profit growth on both YoY and QoQ bases. Investors should wait for signs of margin stabilization and demand recovery in the specialty chemicals segment before increasing exposure.

Alkyl Amines Submits Quarterly SEBI Compliance Certificate for Q3 FY26

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 09 Jan 2026, 12:50 PM

Alkyl Amines Chemicals Limited has filed its quarterly compliance certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018. The document confirms that for the quarter ended December 31, 2025, all dematerialization requests were processed by the Registrar and Share Transfer Agent, MUFG Intime India Private Limited. The filing ensures that physical share certificates were properly mutilated, cancelled, and the depositories' names were updated in the company's records. This is a standard regulatory procedure to maintain the integrity of the electronic shareholding system.

Compliance certificate submitted for the quarter ended December 31, 2025
MUFG Intime India Private Limited confirmed processing of all dematerialization requests
Security certificates were mutilated and cancelled after verification as per SEBI norms
The name of depositories has been substituted in the register of members within prescribed timelines

💡 No action is required from investors as this is a routine administrative filing. Focus should remain on the company's upcoming quarterly financial performance.

Alkyl Amines Clarifies No Undisclosed Information Behind Recent Trading Volume Spurt

🟡 NEUTRAL ⭐ 3/10

ROUTINE 📅 09 Jan 2026, 10:50 AM

Alkyl Amines Chemicals Limited has responded to a clarification request from the National Stock Exchange regarding a significant increase in its share trading volume. The company stated that it has consistently complied with all disclosure requirements under Regulation 30 of SEBI (LODR) Regulations, 2015. Management confirmed there is no pending or undisclosed price-sensitive information that could explain the recent volume behavior. This suggests the recent market activity is likely driven by external market factors rather than internal corporate developments.

NSE issued a surveillance query on January 8, 2026, regarding a significant spurt in trading volume.
Company officially responded on January 9, 2026, stating no undisclosed information exists.
Management confirmed full compliance with SEBI Listing Obligations and Disclosure Requirements.
The company denied knowledge of any specific information leading to the recent volume movement.
No impending announcements were identified that could have a bearing on price or volume behavior.

💡 Investors should view the recent volume increase as market-driven and avoid speculative positions based on rumors of undisclosed news. Focus on the company's fundamental performance and upcoming quarterly results for long-term investment decisions.

Alkyl Amines Credit Ratings Reaffirmed at AA-/Stable and A1+ for Rs 189.38 Cr Facilities

🟡 NEUTRAL ⭐ 4/10

ROUTINE 📅 29 Dec 2025, 06:37 PM

CRISIL Ratings has reaffirmed the credit ratings for Alkyl Amines Chemicals Limited's bank loan facilities totaling Rs 189.38 crores. The long-term rating is maintained at 'CRISIL AA-/Stable', while the short-term rating remains at 'CRISIL A1+'. This reaffirmation indicates the company's strong credit profile and its consistent ability to meet financial obligations. The stable outlook suggests that the rating agency expects the company to maintain its business and financial risk profile over the medium term.

CRISIL reaffirmed the Long Term Rating at CRISIL AA- with a Stable outlook
Short Term Rating reaffirmed at the highest possible level of CRISIL A1+
Total bank loan facilities covered under this rating review amount to Rs 189.38 crores
The ratings reflect the company's established market position in the aliphatic amines industry

💡 The reaffirmation confirms the company's creditworthiness and financial health. Investors should view this as a sign of stability, though no immediate portfolio changes are required.

Alkyl Amines to Close Trading Window from Jan 1, 2026 for Q3 FY26 Results

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 29 Dec 2025, 01:21 PM

Alkyl Amines Chemicals Limited has announced the closure of its trading window starting January 1, 2026, in compliance with SEBI Insider Trading regulations. This closure is specifically for the consideration of the company's unaudited financial results for the quarter and nine months ending December 31, 2025. The window will remain closed for all designated persons and their immediate relatives. It is scheduled to reopen 48 hours after the financial results are officially declared to the exchanges.

Trading window closure effective from January 1, 2026.
Closure pertains to the review of financial results for the period ending December 31, 2025.
The window will reopen 48 hours after the declaration of the unaudited financial results.
Compliance follows SEBI (Prohibition of Insider Trading) Regulations, 2015.

💡 This is a routine regulatory announcement and does not require any immediate action. Investors should monitor the upcoming announcement of the Q3 FY26 results for performance insights.

Alkyl Amines Shareholders Approve Remuneration Revision for WTD Rakesh Goyal with 99.89% Majority

🟡 NEUTRAL ⭐ 4/10

MANAGEMENT 📅 22 Dec 2025, 10:05 PM

Alkyl Amines Chemicals Limited has successfully passed a special resolution via postal ballot to revise the remuneration for Mr. Rakesh S. Goyal, Whole-time Director - Operations. The resolution received overwhelming support with 99.89% of the 3.92 crore votes cast in favor. The revised remuneration terms will take effect from January 1, 2026, and continue until May 31, 2027. This approval reflects strong shareholder confidence in the company's leadership and operational management.

Special resolution for revision in remuneration of Mr. Rakesh S. Goyal passed with 99.89% majority.
Total of 3,91,72,848 votes were cast in favor out of 3,92,14,098 total votes polled.
Revised remuneration for the Whole-time Director - Operations is effective from January 1, 2026.
Public institutional holders showed high support with 98.96% of their votes in favor.
The resolution was deemed passed on the final day of e-voting, December 20, 2025.

💡 This is a routine management compensation update with high shareholder backing; no specific action is required. Investors should continue to monitor if management performance remains aligned with compensation levels.

Alkyl Amines Allots 75 Equity Shares Under ESOP 2018

🟡 NEUTRAL ⭐ 2/10

ROUTINE 📅 19 Dec 2025, 01:34 PM

Alkyl Amines Chemicals Limited has approved the allotment of 75 equity shares to eligible employees under its Employees Stock Option Plan 2018. The allotment was finalized via a circular resolution by the Nomination and Remuneration Committee on December 19, 2025. The shares were issued at an exercise price of Rs. 1,040 per share, which includes a premium of Rs. 1,038. This is a very small allotment that results in a negligible increase in the company's total paid-up equity capital.

Allotment of 75 equity shares of face value Rs. 2 each under the AACL ESOP 2018 scheme.
Exercise price for the allotment set at Rs. 1,040 per share.
Total paid-up equity capital increased from Rs. 10,22,87,954 to Rs. 10,22,88,104.
Total number of equity shares outstanding now stands at 5,11,44,052.
New shares rank pari-passu with existing equity shares of the company.

💡 No action is required from investors as this is a routine administrative allotment with no material impact on shareholding or valuation. Focus remains on the company's quarterly earnings and chemical sector trends.

View All ALKYLAMINE Announcements on Live Market Tracking →

💰 Financial Performance

Revenue Growth by Segment

The company operates in a single segment, Specialty Chemicals, which generated a total income of INR 1,601.62 Cr in FY25, representing a 10% growth compared to INR 1,455.66 Cr in FY24. Domestic sales grew 9.1% to INR 1,391.47 Cr from INR 1,275.65 Cr YoY.

Geographic Revenue Split

Domestic sales contributed 86.8% (INR 1,391.47 Cr) of total income in FY25. Export sales contributed 21.4% (INR 343.09 Cr) of total income in FY25, up 7.9% from INR 317.79 Cr in FY24. Exports are expected to increase gradually over the medium term.

Profitability Margins

Profitability has seen compression; PAT margins declined from 13.48% in FY23 to 10.23% in FY24. Profit Before Tax (PBT) for FY25 was INR 248.64 Cr, a 22.8% increase from INR 202.47 Cr in FY24, though margins remain sensitive to raw material price volatility.

EBITDA Margin

Operating margins remained above 20% in FY23 despite raw material volatility. However, credit rating sensitivities suggest a downward risk if margins drop below 17-18% on a sustained basis due to loss of market share or inability to pass on input costs.

Capital Expenditure

The company recently completed a major capital expenditure of INR 400 Cr for a new Ethyl Amines plant at the Kurkumbh site in Maharashtra, which is now fully operational. Further investments in various projects are expected to add to the top-line in FY26.

Credit Rating & Borrowing

The company holds a 'CRISIL AA-/Stable' long-term rating and 'CRISIL A1+' short-term rating (upgraded in May 2023). It maintains a strong financial risk profile with nil long-term debt and low bank limit utilization of approximately 29%.

⚙️ Operational Drivers

Raw Materials

Key raw materials include Alcohols (Ethanol and Methanol), Ammonia, and Acetic Acid. These inputs are highly volatile; Ethanol is linked to the sugar cycle, while Methanol is driven by crude oil prices and global demand-supply dynamics.

Import Sources

Raw materials are sourced both domestically and through imports. Methanol prices are specifically noted to be driven by international market dynamics, and a portion of raw material requirements is met through imports, exposing the company to forex risks.

Key Suppliers

Not specifically named in the documents, but the company relies on suppliers from the sugar industry for Ethanol and international commodity markets for Methanol and Ammonia.

Capacity Expansion

Current saleable capacity is approximately 1.5 lakh tons (representing 75% of total production). A new Ethyl Amines plant (INR 400 Cr investment) is fully operational, and a 5,000-ton capacity for Diethyl Ketone (DEK) was previously commercialized.

Raw Material Costs

Raw material costs are a significant portion of the cost structure. Ammonia prices have recently softened, but the company operates in an oligopolistic environment where passing on price increases can be difficult, making margins susceptible to unfavorable price movements.

Manufacturing Efficiency

The company focuses on ramp-ups in enhanced capacities and sustained operating efficiency backed by volume growth. Approximately 25% of production is consumed internally for derivative manufacturing.

📈 Strategic Growth

Expected Growth Rate

10-15%

Growth Strategy

Growth will be driven by the ramp-up of the new INR 400 Cr Ethyl Amines plant, increasing the contribution of the export segment (target for gradual increase), and expanding the product range in the specialty chemicals and amine derivatives segments.

Products & Services

Aliphatic amines (Ethylamine, Methylamine), amine derivatives, specialty chemicals, and Diethyl Ketone (DEK). These are sold to the pharmaceutical, agro-chemical, water treatment, and rubber chemical industries.

Brand Portfolio

Alkyl Amines Chemicals Limited (AACL).

New Products/Services

The company is expanding its product range and recently commercialized Diethyl Ketone (DEK) with a 5,000-ton capacity, although current utilization is under pressure due to agrochemical market conditions.

Market Expansion

The company is focusing on increasing its export footprint (currently 21.4% of revenue) and leveraging its leadership position in the domestic oligopolistic amines market to capture growing demand in Asia.

Market Share & Ranking

AACL is a leading player with a significant and dominant market share in the Indian aliphatic amines industry, which is characterized as oligopolistic.

Strategic Alliances

The company was promoted by Mr. Yogesh Kothari and family in association with DSP Financial Consultants Ltd.

🌍 External Factors

Industry Trends

The chemical industry is shifting focus toward Asia. While the current environment is complex with subdued pricing, the long-term trend is growing demand for amines in pharma and agro-chemicals, with the industry evolving toward more complex supply chains.

Competitive Landscape

The industry is oligopolistic with intense competition from both local and international producers. AACL is one of the top players in India.

Competitive Moat

The moat is built on a leadership position in an oligopolistic market, high entry barriers due to complex manufacturing, and a strong financial profile with nil long-term debt, making it highly sustainable.

Macro Economic Sensitivity

Highly sensitive to commodity price cycles (sugar and crude oil) and inflationary pressures. A sustained operating margin below 17% is a key monitorable for credit rating downgrades.

Consumer Behavior

Demand is driven by end-user industries like pharmaceuticals and agro-chemicals; recent pressure in the agro-chemical sector has led to lower utilization for specific products like DEK.

Geopolitical Risks

Recent performance in H1 FY26 was described as 'subdued' due to geopolitical pressures and actions by the US government affecting global demand and pricing.

⚖️ Regulatory & Governance

Industry Regulations

Operations are subject to statutory regulations regarding health, safety, and environment. The company underwent a secretarial audit for FY25 to ensure compliance with the Companies Act and SEBI Listing Regulations.

Environmental Compliance

The company adheres to 'Responsible Care' standards and monitors manufacturing sites for environmental protection and operational safety in line with statutory regulations.

⚠️ Risk Analysis

Key Uncertainties

Volatility in raw material prices (Ammonia, Methanol, Ethanol) and forex rates are the primary uncertainties. A decline in operating margins below 18% could trigger a rating downgrade.